June 2024
1. ABDEL-MONEIM AS, Murovska M, Soderlund-Venermo M, Vakharia VN, et al
   WSV2023 - The second meeting of the world society for virology: One health - One world - One virology.
   Virology. 2024;594:110049.
   

   >> Share

   
   
2. HE X, Jiang N, Li Y
   Saccharomyces cerevisiae cells that display norovirus P induce both systemic and mucosal neutralizing antibodies.
   Virology. 2024;594:110034.
   

   >> Share

   
   April 2024
3. MA X, Wang Q, Xu X, Zhang W, et al
   miR-214-PTEN pathway is a potential mechanism for stress-induced immunosuppression affecting chicken immune response to avian influenza virus vaccine.
   Virology. 2024;595:110094.
   

   >> Share

   
   
4. KIM KH, Bhatnagar N, Subbiah J, Liu R, et al
   Cross-protection against influenza viruses by chimeric M2e-H3 stalk protein or multi-subtype neuraminidase plus M2e virus-like particle vaccine in ferrets.
   Virology. 2024;595:110097.
   

   >> Share

   
   
5. ZHANG F, Chai Z, Wang X, Zhang Z, et al
   Monkeypox: Can we count on the current smallpox immunization?
   Virology. 2024;592:109994.
   

   >> Share

   
   March 2024
6. AMOSOVA IV, Timoshicheva TA, Kadyrova RA, Zabrodskaya YA, et al
   The investigation of the dynamics of changes in neutralizing antibody titers against type 5 adenovirus in the context of vaccination against a new coronavirus infection.
   Virology. 2024;594:110051.
   

   >> Share

   
   
7. ZHENG X, Yang R, Zhao Y, Zhang Y, et al
   Alum/CpG adjuvant promotes immunogenicity of inactivated SARS-CoV-2 Omicron vaccine through enhanced humoral and cellular immunity.
   Virology. 2024;594:110050.
   

   >> Share

   
   
8. HUONG TN, Lee ZQ, Lai SK, Lee HY, et al
   Evidence that an interaction between the respiratory syncytial virus F and G proteins at the distal ends of virus filaments mediates efficient multiple cycle infection.
   Virology. 2024;591:109985.
   

   >> Share

   
   February 2024
9. MA B, Tao M, Li Z, Zheng Q, et al
   Mucosal vaccines for viral diseases: Status and prospects.
   Virology. 2024;593:110026.
   

   >> Share

   
   December 2023
10. FAZEL F, Matsuyama-Kato A, Alizadeh M, Boodhoo N, et al
    Efficacy and tolerability of an mRNA vaccine expressing gB and pp38 antigens of Marek's disease virus in chickens.
    Virology. 2023;590:109970.
    

    >> Share

    
    
11. YU R, Zhang L, Zhou P, Zhang Z, et al
    Evaluation of the immunoprotective effects of porcine deltacoronavirus subunit vaccines.
    Virology. 2023;590:109955.
    

    >> Share

    
    October 2023
12. LATIFI T, Jalilvand S, Golsaz-Shirazi F, Arashkia A, et al
    Characterization and immunogenicity of a novel chimeric hepatitis B core-virus like particles (cVLPs) carrying rotavirus VP8*protein in mice model.
    Virology. 2023;588:109903.
    

    >> Share

    
    August 2023
13. GOSAVI M, Kulkarni-Munje A, Patil HP
    Dual pattern recognition receptor ligands CL401, CL413, and CL429 as adjuvants for inactivated chikungunya virus.
    Virology. 2023;585:82-90.
    

    >> Share

    
    June 2023
14. SU R, Shi Z, Li E, Zhu M, et al
    A Trim-RBD-GEM vaccine candidate protects mice from SARS-CoV-2.
    Virology. 2023;585:145-154.
    

    >> Share

    
    May 2023
15. CHENCHULA S, Amerneni KC, Ghanta MK, Padmavathi R, et al
    Clinical virology and effect of Covid-19 vaccination and monoclonal antibodies against highly infectious SARS- CoV-2 omicron sub variant BF.7 (BA.5.2.1.7): A systematic review.
    Virology. 2023;584:38-43.
    

    >> Share

    
    
16. MIAO X, Zhang L, Zhou P, Zhang Z, et al
    Recombinant human adenovirus type 5 based vaccine candidates against GIIa- and GIIb-genotype porcine epidemic diarrhea virus induce robust humoral and cellular response in mice.
    Virology. 2023;584:9-23.
    

    >> Share

    
    March 2023
17. ZHANG Z, Yao F, Lv J, Ding Y, et al
    Identification of B-cell epitopes on structural proteins VP1 and VP2 of Senecavirus A and development of a multi-epitope recombinant protein vaccine.
    Virology. 2023;582:48-56.
    

    >> Share

    
    
18. MANU M, Singha Mahapatra C, Pachauri R, Ompreethi B, et al
    Evaluation of an alternative method for determination of Protective Dose(50) of Classical swine fever vaccines.
    Virology. 2023;581:139-144.
    

    >> Share

    
    
19. ADAMS A, Hendrikse M, Rybicki EP, Hitzeroth II, et al
    Optimal size of DNA encapsidated by plant produced human papillomavirus pseudovirions.
    Virology. 2023;580:88-97.
    

    >> Share

    
    February 2023
20. CHA SH, You SH, Lee MA, Baek JH, et al
    Application of codon pair deoptimization for ORF7-induced attenuation of type I porcine reproductive and respiratory syndrome virus without reduced immune responses.
    Virology. 2023;579:119-127.
    

    >> Share

    
    
21. TANG H, Wang H, Yang L, Chen H, et al
    Immunogenicity analysis of the E. coli expressed structural protein VP1 of persistent infection foot-and-mouth disease virus.
    Virology. 2023;579:111-118.
    

    >> Share

    
    
22. ZHANG C, Zhang Y, Li Y, Lu J, et al
    Exosome-based delivery of VP1 protein conferred enhanced resistance of mice to CVB3-induced viral myocarditis.
    Virology. 2023;579:46-53.
    

    >> Share

    
    January 2023
23. JI C, Zhang Y, Feng Y, Zhang X, et al
    A polymerase mechanism-based strategy constructing attenuated clones of enterovirus for vaccine vector development.
    Virology. 2023;580:1-7.
    

    >> Share

    
    
24. ZHENG C, Liang Z, Lin Q, Chen M, et al
    Pathology, viremia, apoptosis during MDV latency in vaccinated chickens.
    Virology. 2023;579:169-177.
    

    >> Share

    
    December 2022
25. DEHGANI-MOBARAKI P, Wang C, Floridi A, Floridi E, et al
    Long-term persistence of IgG antibodies in recovered COVID-19 individuals at 18 months post-infection and the impact of two-dose BNT162b2 (Pfizer-BioNTech) mRNA vaccination on the antibody response: Analysis using fixed-effects linear regression model
    Virology. 2022;578:111-116.
    

    >> Share

    
    November 2022
26. HU Z, Chen JP, Xu JC, Chen ZY, et al
    Corrigendum to "A two-dose optimum for recombinant S1 protein-based COVID-19 vaccination" [Virology 566 (2022) 56-59].
    Virology. 2022;578:22-23.
    

    >> Share

    
    
27. SANTOS LA, Almeida F, Giria M, Trigueiro-Louro J, et al
    Adaptive evolution of PB1 from influenza A(H1N1)pdm09 virus towards an enhanced fitness.
    Virology. 2022;578:1-6.
    

    >> Share

    
    October 2022
28. LAMICHHANE P, Schmidt ME, Terhuja M, Varga SM, et al
    A live single-cycle RSV vaccine expressing prefusion F protein.
    Virology. 2022;577:51-64.
    

    >> Share

    
    
29. BRAKEL KA, Ma Y, Binjawadagi R, Harder O, et al
    Codon-optimization of the respiratory syncytial virus (RSV) G protein expressed in a vesicular stomatitis virus (VSV) vector improves immune responses in a cotton rat model.
    Virology. 2022;575:101-110.
    

    >> Share

    
    September 2022
30. TANG CY, Boftsi M, Staudt L, McElroy JA, et al
    SARS-CoV-2 and influenza co-infection: A cross-sectional study in central Missouri during the 2021-2022 influenza season.
    Virology. 2022;576:105-110.
    

    >> Share

    
    
31. WANG R, Huang X, Cao T, Sun C, et al
    Development of a thermostable SARS-CoV-2 variant-based bivalent protein vaccine with cross-neutralizing potency against Omicron subvariants.
    Virology. 2022;576:61-68.
    

    >> Share

    
    August 2022
32. OLCZAK P, Wong M, Tsai HL, Wang H, et al
    Vaccination with human alphapapillomavirus-derived L2 multimer protects against human betapapillomavirus challenge, including in epidermodysplasia verruciformis model mice.
    Virology. 2022;575:63-73.
    

    >> Share

    
    
33. KONG D, Wen Z, Su H, Ge J, et al
    Corrigendum to "Newcastle disease virus vectored Nipah encephalitis vaccines induce B and T cell responses in mice and long-lasting neutralizing antibodies in pigs" [Virology 432 (2012) 327-335].
    Virology. 2022;573:176-177.
    

    >> Share

    
    July 2022
34. OH J, Subbiah J, Kim KH, Park BR, et al
    Impact of hemagglutination activity and M2e immunity on conferring protection against influenza viruses.
    Virology. 2022;574:37-46.
    

    >> Share

    
    June 2022
35. LIM H, Kim SE, Lee YH, Hwang YH, et al
    Immunogenicity of candidate SARS-CoV-2 DNA vaccines based on the spike protein.
    Virology. 2022;573:118-123.
    

    >> Share

    
    May 2022
36. KHAN K, Khan SA, Jalal K, Ul-Haq Z, et al
    Immunoinformatic approach for the construction of multi-epitopes vaccine against omicron COVID-19 variant.
    Virology. 2022;572:28-43.
    

    >> Share

    
    April 2022
37. NGUYEN NH, Nguyen PBT, Nguyen TQ, Do DT, et al
    Genotypic diversity of CSFV field strains: A silent risk reduces vaccination efficacy of CSFV vaccines in Vietnam.
    Virology. 2022;571:39-45.
    

    >> Share

    
    
38. MI T, Wang T, Xu H, Sun P, et al
    Kappa-RBD produced by glycoengineered Pichia pastoris elicited high neutralizing antibody titers against pseudoviruses of SARS-CoV-2 variants.
    Virology. 2022;569:56-63.
    

    >> Share

    
    February 2022
39. CHEN X, Sun HY, Lee CY, Rostad CA, et al
    Functional antibody-dependent cell mediated cytotoxicity (ADCC) responses to vaccine and circulating influenza strains following vaccination.
    Virology. 2022;569:44-55.
    

    >> Share

    
    January 2022
40. MATSUYAMA-KATO A, Iseki H, Boodhoo N, Bavananthasivam J, et al
    Phenotypic characterization of gamma delta (gammadelta) T cells in chickens infected with or vaccinated against Marek's disease virus.
    Virology. 2022;568:115-125.
    

    >> Share

    
    
41. ROSENGARTEN JF, Schatz S, Wolf T, Barbe S, et al
    Components of a HIV-1 vaccine mediate virus-like particle (VLP)-formation and display of envelope proteins exposing broadly neutralizing epitopes.
    Virology. 2022;568:41-48.
    

    >> Share

    
    December 2021
42. PARK BR, Subbiah J, Kim KH, Kwon YM, et al
    Enhanced cross protection by hetero prime-boost vaccination with recombinant influenza viruses containing chimeric hemagglutinin-M2e epitopes.
    Virology. 2021;566:143-152.
    

    >> Share

    
    
43. KORNUTA CA, Cheuquepan F, Bidart JE, Soria I, et al
    TLR activation, immune response and viral protection elicited in cattle by a commercial vaccine against Bovine Herpesvirus-1.
    Virology. 2021;566:98-105.
    

    >> Share

    
    
44. HEINIMAKI S, Lampinen V, Tamminen K, Hankaniemi MM, et al
    Antigenicity and immunogenicity of HA2 and M2e influenza virus antigens conjugated to norovirus-like, VP1 capsid-based particles by the SpyTag/SpyCatcher technology.
    Virology. 2021;566:89-97.
    

    >> Share

    
    
45. HU Z, Chen JP, Xu JC, Chen ZY, et al
    A two-dose optimum for recombinant S1 protein-based COVID-19 vaccination.
    Virology. 2021;566:56-59.
    

    >> Share

    
    November 2021
46. SHI D, Fan B, Sun B, Zhou J, et al
    LDH nanoparticle adjuvant subunit vaccine induces an effective immune response for porcine epidemic diarrhea virus.
    Virology. 2021;565:58-64.
    

    >> Share

    
    October 2021
47. AHMED SM, Nasr MA, Elshenawy SE, Hussein AE, et al
    BCG vaccination and the risk of COVID 19: A possible correlation.
    Virology. 2021;565:73-81.
    

    >> Share

    
    March 2021
48. GAO W, Yue L, Yang T, Li H, et al
    A comparative study on biological characteristics of ten coxsackievirus A10 virus strains.
    Virology. 2021;555:1-9.
    

    >> Share

    
    November 2020
49. POWELL JD, Abente EJ, Chang J, Souza CK, et al
    Characterization of contemporary 2010.1 H3N2 swine influenza A viruses circulating in United States pigs.
    Virology. 2020;553:94-101.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share